177Lu-DOTA-EB-TATE
N/A
Report date: 2026/02/18 20:02:09
NME
Base Information
Drug Name177Lu-DOTA-EB-TATE
Drug Alias Name
Classification +[4]
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPending
Originator CompaniesNational Institute of Biomedical Imaging and Bioengineering
China Registration ClassN/A
Develop Information
Active CompaniesNational Institute For Biomedical Imaging And Bioengineering (Nibib)Peking Union Medical College HospitalMolecular Targeting Technologies Inc +[4]
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A